ImmuCell Corp (ICCC)

4.45 -0.01  -0.28% NASDAQ Jun 3, 20:00 Delayed 2m USD

ImmuCell Shareholders Equity (Quarterly):

28.99M for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Shareholders Equity (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Shareholders Equity (Quarterly) Data

View and export this data going back to 1989. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 28.99M
Dec. 31, 2019 28.99M
Sept. 30, 2019 29.19M
June 30, 2019 29.64M
March 31, 2019 30.25M
Dec. 31, 2018 21.74M
Sept. 30, 2018 22.67M
June 30, 2018 22.81M
March 31, 2018 23.49M
Dec. 31, 2017 23.59M
Sept. 30, 2017 20.95M
June 30, 2017 20.20M
March 31, 2017 20.37M
Dec. 31, 2016 19.72M
Sept. 30, 2016 16.41M
June 30, 2016 16.31M
March 31, 2016 16.32M
Dec. 31, 2015 10.61M
Sept. 30, 2015 10.30M
June 30, 2015 9.904M
March 31, 2015 9.743M
Dec. 31, 2014 9.258M
Sept. 30, 2014 9.124M
June 30, 2014 9.103M
March 31, 2014 9.392M
   
Dec. 31, 2013 9.396M
Sept. 30, 2013 9.511M
June 30, 2013 9.446M
March 31, 2013 9.413M
Dec. 31, 2012 9.195M
Sept. 30, 2012 9.199M
June 30, 2012 9.258M
March 31, 2012 9.247M
Dec. 31, 2011 9.020M
Sept. 30, 2011 8.994M
June 30, 2011 9.045M
March 31, 2011 9.269M
Dec. 31, 2010 9.282M
June 30, 2010 9.577M
March 31, 2010 9.583M
Dec. 31, 2009 9.622M
Sept. 30, 2009 9.619M
June 30, 2009 9.617M
March 31, 2009 9.742M
Dec. 31, 2008 9.644M
Sept. 30, 2008 9.712M
June 30, 2008 9.951M
March 31, 2008 10.16M
Dec. 31, 2007 10.06M
Sept. 30, 2007 9.962M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Benchmarks

Benchmarks
Emergent BioSolutions Inc 1.075B
Johnson & Johnson 61.29B
Fate Therapeutics Inc 219.22M

Shareholders Equity (Quarterly) Range, Past 5 Years

Minimum 9.904M Jun 2015
Maximum 30.25M Mar 2019
Average 21.12M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.